Author

Shanna Su 1

1 Western General Hospital,Edin

LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD

Heather Dolby, Laura Lucaciu, Caitlin Rees, Mathew Lyons, Lauranne Derikx, Nikolas Plevris, Shanna Su, Claire O'Hare, Laura Kirkpatrick, Lynne Merchant, Ian D Arnott, Nathan Constantine-Cook, Spyridon (Spyros) Siakavellas, Colin Noble, Philip Jenkinson, Gareth R Jones, Charlie Lees

Item 1 - 1 / 1
1